分区性炎症景观和巨细胞的可塑性调节Tet2+/-介导的克隆性血液形成
Kevin Lee1, Cih-Li Hong2, Wimeth Dissanayake2
1University of Rochester, Rochester, New York, United States.
Blood
|January 12, 2026
概括
不确定潜力的克隆性血液形成 (CHIP) 受骨重塑的影响. 准骨重塑和巨细胞可以减轻CHIP克隆扩张,揭示了克隆血液疾病的新治疗策略.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 骨生物学 骨生物学 骨生物学
背景情况:
- 不确定潜力的克隆性血液形成 (CHIP) 涉及血液形成干细胞 (HSC) 中的白血病相关突变.
- 骨髓的空间组织和炎症对克隆扩张有影响,但CHIP中局部骨改造的作用尚不清楚.
研究的目的:
- 调查骨头重塑如何影响CHIP中非恶性突变克隆的扩张.
- 阐明骨髓微环境,炎症和CHIP进展之间的相互作用.
主要方法:
- 内脏成像和CHIP的Tet2+/-小鼠模型.
- 空间分辨的单细胞转录组分析和功能评估.
- 药物抑制骨重塑 (zoledronate) 和向巨细胞相关的利基因素.
主要成果:
- 证明了骨髓微环境的转录和功能细分.
- 在非吸收性腔体中确定了抑制Tet2+/-细胞的抗炎巨体.
- 揭示了骨头重塑会影响巨细胞的可塑性和细胞因子分泌,调节克隆负担.
- 在微环境中观察到抗瘤免疫的早期变化.
- 表明抑制骨重塑或向巨细胞可以减轻克隆发育.
结论:
- 当地骨头重塑塑造了一个独特的炎症景观,影响CHIP的进展.
- 巨细胞在特定骨髓内的CHIP克隆的调节中发挥着关键作用.
- 针对骨重塑和巨相关因素,为克隆性血液疾病提供了潜在的治疗策略.
更多相关视频
06:38Macrophage Differentiation and Polarization into an M2-Like Phenotype using a Human Monocyte-Like THP-1 Leukemia Cell Line
Published on: August 2, 2021
31.1K
11:06Combining Intravital Fluorescent Microscopy IVFM with Genetic Models to Study Engraftment Dynamics of Hematopoietic Cells to Bone Marrow Niches
Published on: March 21, 2017
8.3K
相关概念视频
Regulation of Hematopoietic Stem Cells
3.9K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.9K
Multipotency of Hematopoietic Stem Cells
3.8K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.8K
Lineage Commitment
4.1K
Commitment is the process whereby stem cells:
4.1K
Hematopoiesis
8.6K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
8.6K
Differentiation of Common Myeloid Progenitor Cells
3.9K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.9K
Production of Formed Elements
3.6K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
3.6K
